N
ADPT icon

Natixis’s Adaptive Biotechnologies ADPT Stock Holding History

Natixis’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-47,600
Closed -$712K – 1114
2025
Q3 		$712K Buy
+47,600
New +$580K ﹤0.01% 731
2022
Q2 		– Sell
-157,474
Closed -$2.19M – 1140
2022
Q1 		$2.19M Buy
+157,474
New +$2.48M 0.01% 733
2021
Q4 		– Sell
-5,905
Closed -$201K – 1213
2021
Q3 		$201K Sell
5,905
-47
-0.8% -$1.7K ﹤0.01% 1148
2021
Q2 		$243K Sell
5,952
-62,122
-91% -$2.42M ﹤0.01% 800
2021
Q1 		$2.74M Buy
68,074
+41,874
+160% +$2.27M 0.01% 628
2020
Q4 		$1.55M Sell
26,200
-36,380
-58% -$1.88M 0.01% 729
2020
Q3 		$3.04M Buy
+62,580
New +$2.63M 0.02% 354

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return